The United Nations has adopted 17 SDG (Sustainability Development Goals) in 2015 stating that development must balance social, economic, and environmental sustainability¹. In recent years, several countries in the APAC region have made early commitments to reduce GHG emissions, aiming to achieve significant reductions by as early as 2030². Amid growing prioritisation of Environmental, Social and Governance (ESG) considerations for companies across the globe; APACMed has partnered with Bain and Co. to focus on ESG as a strategic priority for MedTech in APAC.
In this second edition of the Environmental Regulatory Dashboard, we brought together nominated representatives from 18 member companies including Abbott, BBraun, CMR Surgical, Convatec, Cook Medical, Fresenius Medical Care, Invisalign, Johnson & Johnson, Karl Storz, Medtronic, Olympus, Philips, Resmed, Roche, Steris, Stryker, Teleflex Medical, and Varian, supported by Bain & Company.
The dashboard aims to understand the challenges faced by MedTech players in navigating the ESG landscape from different stakeholders perspectives – policymakers, customers, employees and executives. The 2024 edition of the dashboard covers evolving environmental regulations for 9 key APAC markets (Australia, China, India, Japan, Malaysia, Singapore, South Korea, Thailand and Vietnam). For each country, the dashboard provides a detailed landscape scan of what is required to navigate the market on specific environmental themes.
New features in the 2024 edition include:
• A handy summary page to view key highlights for a country at a glance
• New drop-down menus to filter information
• A new country comparison tool to compare policies between markets
• Streamlined navigation and user interface
Please note that the full dashboard is accessible by members only – member login is required to access.
For Members Only
For Public
